$5995 | Single User
$11990 | Site License
$17985 | Enterprise License

MediPoint: Point of Care Diagnostics - Global Analysis and Market Forecasts
[Lowest Price Guaranteed: $5,995]

Published by Global Data: 01 Mar 2016 | 26649 | In Stock

Introduction

MediPoint: Point of Care Diagnostics - Global Analysis and Market Forecasts

Summary

Point-of-care testing (POCT), as known as bedside/near-patient testing is one of the most rapidly growing areas in IVD. Systems that are categorized as POC include the following -

- Disposable systems or devices, which vary from reagent test strips for a single analyte to multi-analyte reagent strips

- Small analyzers, usually hand-held devices

- Desktop analyzers are larger and include systems designed for use in clinics or small laboratories.

POCT may be performed in a variety of locations such as in secondary care including emergency departments, ambulance service, hospital wards, and intensive treatment units; and increasingly in the community and primary care including general practice (GP), health and community centers.

- billion in annual global sales and growth rate of 5.3% during the forecast period; the emerging markets: China, India and Brazil, are expected to show the fastest growth.

- A number of factors, such as the increasing prevalence of infectious diseases in developing countries, the rising incidences of lifestyle diseases such as cardiac diseases and diabetes, the rising usage of home-based POC devices, expansion of test menu, and advancements in molecular testing and lab-on-chip technology are stimulating the demand for POC testing.

- The rate of POC testing adoption will be moderated by the requirement for regulatory compliance, the pressure to control cost, and the need to demonstrate clear clinical-cost benefits of POC testing over central laboratory testing.

Highlights

Key Questions Answered

- What is the current and future POC diagnostics market outlook in the developed and emerging markets? What trends are affecting the global market?

- What is the competitive landscape and market share of major players in the POC space across different regions?

- What are the key, high growth markets that IVD manufacturers should expand into? Which market segments are growing the fastest?

- What are the unmet needs with the POC tests currently on the market? How will emerging technologies such as molecular POC assays fulfil these unmet needs?

- What are the key factors influencing a physician to use POC tests? What is physician perception and market outlook of POC devices?

- What are the challenges and barriers that have hindered widespread adoption of POC devices?

Scope

- Competitive assessment: Currently marketed POC products and evolving competitive landscape

- In-depth analysis of unmet needs and adoption trends of different POC devices

- Insightful review of the key industry drivers, opportunities, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications

- Pipeline analysis: Emerging products and technologies.

- Annualized total POC diagnostics market revenue by segment and market outlooks by country from 2012-2021.

- Other key topics covered include strategic competitive assessment, market characterization, identification of unmet needs, market dynamics, and implications of the emerging technologies on the market.

Reasons to buy

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline

- Develop business strategies by understanding the trends shaping and driving the global market

- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global market in the future

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors

- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage

- Track device sales in the global market from 2012-2021

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships

Table of Contents
for MediPoint: Point of Care Diagnostics - Global Analysis and Market Forecasts

  • 1 Table of Contents

    1 Table of Contents 8

    1.1 List of Tables 12

    1.2 List of Figures 16

    2 Introduction 18

    2.1 Catalyst 18

    2.2 Related Reports 18

    3 Industry Overview 19

    3.1 POC Diagnostics Overview 19

    3.2 Test Trends 21

    3.2.1 Cardiac Markers POC Testing 21

    3.2.2 Female Fertility and Pregnancy POC Testing 24

    3.3 Mergers, Acquisitions, and Key Partnerships 29

    4 Unmet Needs 33

    4.1 Detection of Multiple Analytes 33

    4.2 Sensitivity of Lateral Flow Technology 33

    4.3 Analytical Quality 35

    4.4 Markers for Myocardial Ischemia 35

    4.5 Data Management 36

    4.6 POC Diagnostics to Reduce Usage of Antibiotics 37

    4.7 Cost-Effectiveness and Reimbursement 38

    4.8 Gap between Physicians and Manufacturers 39

    5 Market Drivers and Barriers 40

    5.1 Drivers 40

    5.1.1 Fast Turnaround Time 40

    5.1.2 POC Molecular Testing Driving Infectious Disease POCT 40

    5.1.3 Increasing Adoption of Cardiac Marker POCT 41

    5.1.4 Expansion POC Testing Menu 42

    5.1.5 Expansion of the Home-Testing Market 43

    5.1.6 CLIA Waived Status for POCT 43

    5.1.7 Rising Prevalence of Diseases 44

    5.2 Barriers 44

    5.2.1 Management of POCT 44

    5.2.2 Competition with Laboratory Tests 45

    5.2.3 Regulatory Compliance 46

    5.2.4 Medical Device Excise Tax 47

    6 Competitive Assessment 48

    6.1 Company Share Analysis 48

    6.1.1 Global 48

    6.1.2 US 49

    6.1.3 Europe 50

    6.1.4 Asia-Pacific 51

    6.2 Trends in Corporate Strategy 52

    6.3 Major Players 53

    6.3.1 Abbott Diagnostics 53

    6.3.2 Akers Bioscience 56

    6.3.3 Alere 59

    6.3.4 Beckman Coulter 64

    6.3.5 BioMerieux 66

    6.3.6 Chembio Diagnostics 69

    6.3.7 EKF Diagnostics 72

    6.3.8 Meridian Bioscience 75

    6.3.9 OraSure Technologies 79

    6.3.10 Quidel 82

    6.3.11 Radiometer Medical 86

    6.3.12 Response Biomedical 89

    6.3.13 Roche Diagnostics 93

    6.3.14 Siemens Healthcare 97

    6.3.15 Trinity Biotech 100

    6.3.16 Other Companies 104

    7 Pipeline Assessment 116

    7.1 Overview 116

    7.2 Pipeline Profiles 117

    7.2.1 Cardiac Markers POCT 117

    7.2.2 Female Fertility and Pregnancy POCT 118

    7.2.3 Hematology POCT 118

    7.2.4 Infectious Disease POCT 119

    7.2.5 Immunochemistry POCT Analyzers 125

    8 Market Outlook 126

    8.1 By Market Segment 126

    8.1.1 Global Overview 126

    8.1.2 Cardiac Markers POCT 128

    8.1.3 Female Fertility and Pregnancy POCT 130

    8.1.4 Hematology POCT 132

    8.1.5 Infectious Disease POCT 133

    8.1.6 Immunochemistry POCT Analyzers 134

    8.2 By Geography 136

    8.2.1 Global Overview 136

    8.2.2 US 139

    8.2.3 France 141

    8.2.4 Germany 144

    8.2.5 Italy 146

    8.2.6 Spain 150

    8.2.7 UK 152

    8.2.8 Japan 156

    8.2.9 China 158

    8.2.10 India 161

    8.2.11 Brazil 164

    9 Appendix 168

    9.1 Bibliography 168

    9.2 Abbreviations 172

    9.3 Report Methodology 177

    9.3.1 Overview 177

    9.3.2 Coverage 177

    9.3.3 Secondary Research 177

    9.3.4 Forecasting Methodology 178

    9.3.5 Primary Research — Key Opinion Leader Interviews 179

    9.3.6 Primary Research - Physician and Industry Interviews 180

    9.3.7 Expert Panel Validation 181

    9.4 Physicians and Specialists Included in This Study 182

    9.5 About the Authors 183

    9.5.1 Analysts 183

    9.5.2 Tyler Fletcher, Global Head of Medical Devices 184

    9.6 About MediPoint 185

    9.7 About GlobalData 185

    9.8 Disclaimer 185

List Of Tables
in MediPoint: Point of Care Diagnostics - Global Analysis and Market Forecasts

1.1 List of Tables

Table 1: Advantages and Disadvantages of POCT 20

Table 2: Global Troponin POCT Volume (thousands) Forecast by Country, 2012-2021 22

Table 3: Global B-type Natriuretic Peptide POCT Volume (thousands) Forecast by Country, 2012-2021 23

Table 4: Global Follicle-Stimulating Hormone POCT Volume Forecast by Country, 2012-2021 25

Table 5: Global Luteinizing Hormone POCT Volume (thousands) Forecast by Country, 2012-2021 27

Table 6: Global Human Chorionic Gonadotropin POCT Volume (thousands) Forecast by Country, 2012-2021 28

Table 7: Mergers, Acquisitions, and Key Partnerships, 2012-2016 30

Table 8: Company Profile - Abbott Diagnostics 54

Table 9: Abbott Diagnostics’ POC Portfolio Assessment, 2015 55

Table 10: SWOT Analysis - Abbott Diagnostics 56

Table 11: Company Profile - Akers Bioscience 57

Table 12: Aker Bioscience’s POC Portfolio Assessment, 2015 58

Table 13: SWOT Analysis - Akers Bioscience 58

Table 14: Company Profile - Alere 60

Table 15: Alere’s POC Portfolio Assessment, 2015 61

Table 16: SWOT Analysis - Alere 64

Table 17: Company Profile - Beckman Coulter 65

Table 18: Beckman Coulter’s POC Portfolio Assessment, 2015 65

Table 19: SWOT Analysis - Beckman Coulter 66

Table 20: Company Profile - BioMerieux 67

Table 21: BioMerieux’s POC Portfolio Assessment, 2015 68

Table 22: SWOT Analysis - BioMerieux 69

Table 23: Company Profile - Chembio Diagnostics 70

Table 24: Chembio Diagnostics’ POC Portfolio Assessment, 2015 71

Table 25: SWOT Analysis - Chembio Diagnostics 72

Table 26: Company Profile - EKF Diagnostics 73

Table 27: EKF Diagnostics’ POC Portfolio Assessment, 2015 74

Table 28: SWOT Analysis - EKF Diagnostics 75

Table 29: Company Profile - Meridian Bioscience 77

Table 30: Meridian Bioscience’s POC Portfolio Assessment, 2015 78

Table 31: SWOT Analysis - Meridian Bioscience 79

Table 32: Company Profile - OraSure Technologies 80

Table 33: OraSure Technologies’ POC Portfolio Assessment, 2015 81

Table 34: SWOT Analysis - OraSure Technologies 81

Table 35: Company Profile - Quidel 83

Table 36: Quidel’s POC Portfolio Assessment, 2015 84

Table 37: SWOT Analysis - Quidel 86

Table 38: Company Profile - Radiometer Medical 87

Table 39: Radiometer Medical’s POC Portfolio Assessment, 2015 88

Table 40: SWOT Analysis - Radiometer Medical 89

Table 41: Company Profile - Response Biomedical 91

Table 42: Response Biomedical’s POC Portfolio Assessment, 2015 92

Table 43: SWOT Analysis - Response Biomedical 93

Table 44: Company Profile - Roche Diagnostics 95

Table 45: Roche Diagnostics’ POC Portfolio Assessment, 2015 96

Table 46: SWOT Analysis - Roche Diagnostics 97

Table 47: Company Profile - Siemens Healthcare 98

Table 48: Siemens Healthcare’s POC Portfolio Assessment, 2015 99

Table 49: SWOT Analysis - Siemens Healthcare 100

Table 50: Company Profile - Trinity Biotech 101

Table 51: Trinity Biotech’s POC Portfolio Assessment, 2015 102

Table 52: SWOT Analysis - Trinity Biotech 103

Table 53: Other POC Companies in North America, 2015 104

Table 54: Other POC Companies in Europe, 2015 111

Table 55: Other POC Companies in APAC and Other Regions, 2015 114

Table 56: Key Cardiac Markers POCT Pipelines, 2015 117

Table 57: Key Female Fertility and Pregnancy POCT Pipelines, 2015 118

Table 58: Key Hematology POCT Pipelines, 2015 118

Table 59: Key Infectious Disease POCT Pipelines, 2015 119

Table 60: Key Immunochemistry POCT Analyzer Pipelines, 2015 125

Table 61: Global POC Diagnostics Sales Forecast ($m) by Market Segment, 2012-2021 127

Table 62: Cardiac Marker POCT Sales Forecast ($m), 2012-2021 130

Table 63: Fertility and Pregnancy POCT Sales Forecast ($m), 2012-2021 131

Table 64: Hematology POCT Sales Forecast ($m), 2012-2021 132

Table 65: Infectious Disease POCT Sales Forecast ($m), 2012-2021 134

Table 66: Immunochemistry POCT Analyzers Sales Forecast ($m), 2012-2021 135

Table 67: Global POC Diagnostics Sales Forecast ($m) by Country, 2012-2021 136

Table 68: US POC Diagnostics Sales Forecast ($m), 2012-2021 140

Table 69: France POC Diagnostics Sales Forecast ($m), 2012-2021 142

Table 70: Germany POC Diagnostics Sales Forecast ($m), 2012-2021 145

Table 71: Italy POC Diagnostics Sales Forecast ($m), 2012-2021 147

Table 72: Spain POC Diagnostics Sales Forecast ($m), 2012-2021 150

Table 73: UK POC Diagnostics Sales Forecast ($m), 2012-2021 153

Table 74: Japan POC Diagnostics Sales Forecast ($m), 2012-2021 156

Table 75: China POC Diagnostics Sales Forecast ($m), 2012-2021 160

Table 76: India POC Diagnostics Sales Forecast ($m), 2012-2021 162

Table 77: Brazil POC Diagnostics Sales Forecast ($m), 2012-2021 166

Table 78: POC Diagnostics - Primary Call Count by Country 180

List Of Figures, Charts and Diagrams
in MediPoint: Point of Care Diagnostics - Global Analysis and Market Forecasts

1.2 List of Figures

Figure 1: Troponin POCT Volume by Country, 2012-2021 22

Figure 2: B-type Natriuretic Peptide POCT Volume by Country, 2012-2021 24

Figure 3: Follicle-Stimulating Hormone POCT Volume by Country, 2012-2021 26

Figure 4: Luteinizing Hormone POCT Volume by Country, 2012-2021 27

Figure 5: Human Chorionic Gonadotropin POCT Volume by Country, 2012-2021 29

Figure 6: Global POC Diagnostics Market, By Company Share, 2015 49

Figure 7: US POC Diagnostics Market, By Company Share, 2015 50

Figure 8: Europe POC Diagnostics Market, By Company Share, 2015 51

Figure 9: APAC POC Diagnostics Market, By Company Share, 2015 52

Figure 10: Global POC Diagnostics Sales Forecast ($m) by Market Segment, 2012-2021 127

Figure 11: Global POC Diagnostics Market Potential by Segment, 2021 128

Figure 12: Cardiac Marker POCT Sales Forecast ($m), 2012-2021 130

Figure 13: Fertility and Pregnancy POCT Sales Forecast ($m), 2012-2021 131

Figure 14: Hematology POCT Sales Forecast ($m), 2012-2021 133

Figure 15: Infectious Disease POCT Sales Forecast ($m), 2012-2021 134

Figure 16: Immunochemistry POCT Analyzers Sales Forecast ($m), 2012-2021 135

Figure 17: Global POC Diagnostics Sales Forecast ($m), 2012-2021 137

Figure 18: Global POC Diagnostics Market Share Forecast ($m) by Country, 2015 and 2021 138

Figure 19: Global POC Diagnostics Market Potential by Country, 2021 139

Figure 20: US POC Diagnostics Sales Forecast ($m), 2012-2021 140

Figure 21: US POC Diagnostics Market Revenue Breakdown, by Segment, 2015 141

Figure 22: France POC Diagnostics Sales Forecast ($m), 2012-2021 143

Figure 23: France POC Diagnostics Market Revenue Breakdown, by Segment, 2015 144

Figure 24: Germany POC Diagnostics Sales Forecast ($m), 2012-2021 145

Figure 25: Germany POC Diagnostics Market Revenue Breakdown, by Segment, 2015 146

Figure 26: Italy POC Diagnostics Sales Forecast ($m), 2012-2021 148

Figure 27: Italy POC Diagnostics Market Revenue Breakdown, by Segment, 2015 149

Figure 28: Spain POC Diagnostics Sales Forecast ($m), 2012-2021 151

Figure 29: Spain POC Diagnostics Market Revenue Breakdown, by Segment, 2015 152

Figure 30: UK POC Diagnostics Sales Forecast ($m), 2012-2021 154

Figure 31: UK POC Diagnostics Market Revenue Breakdown, by Segment, 2015 155

Figure 32: Japan POC Diagnostics Sales Forecast ($m), 2012-2021 157

Figure 33: Japan POC Diagnostics Market Revenue Breakdown, by Segment, 2015 158

Figure 34: China POC Diagnostics Sales Forecast ($m), 2012-2021 160

Figure 35: China POC Diagnostics Market Revenue Breakdown, by Segment, 2015 161

Figure 36: India POC Diagnostics Sales Forecast ($m), 2012-2021 163

Figure 37: India POC Diagnostics Market Revenue Breakdown, by Segment, 2015 164

Figure 38: Brazil POC Diagnostics Sales Forecast ($m), 2012-2021 166

Figure 39: Brazil POC Diagnostics Market Revenue Breakdown, by Segment, 2015 167

Figure 40: POC Diagnostics - Primary Call Count by Country (N=390) 180

Additional Details

Publisher

Global Data

Publisher Information

Reference

26649 | GDME0221MAR

Number of Pages

186

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
MediPoint: Contrast Media Injectors - Global Analysis and Market Forecasts
MediPoint: Contrast Media Injectors - Global Analysis and Market ForecastsSummaryContrast media inje...
01 May 2016 by Global Data USD $5,995 More Info
MediPoint: Biopsy Devices - Global Analysis and Market Forecasts
MediPoint: Biopsy Devices - Global Analysis and Market ForecastsSummaryCancer is the uncontrolled gr...
01 Apr 2016 by Global Data USD $5,995 More Info
MediPoint: Renal Denervation - Global Analysis and Market Forecasts
MediPoint: Renal Denervation - Global Analysis and Market ForecastsSummaryRenal denervation catheter...
01 Apr 2016 by Global Data USD $5,995 More Info
MediPoint: Contrast Media - Global Analysis and Market Forecasts
MediPoint: Contrast Media - Global Analysis and Market ForecastsSummaryContrast media are a group of...
01 Apr 2016 by Global Data USD $5,995 More Info
MediPoint: Peripheral Vascular Interventions - Global Analysis and Market Forecasts
MediPoint: Peripheral Vascular Interventions - Global Analysis and Market ForecastsSummaryThe periph...
14 Mar 2016 by Global Data USD $5,995 More Info
MediPoint: Point of Care Diagnostics - Global Analysis and Market Forecasts
MediPoint: Point of Care Diagnostics - Global Analysis and Market ForecastsSummaryPoint-of-care test...
01 Mar 2016 by Global Data USD $5,995 More Info
MediPoint: Electrosurgical Devices - Global Analysis and Market Forecasts
MediPoint: Electrosurgical Devices - Global Analysis and Market ForecastsSummaryElectrosurgical gene...
01 Mar 2016 by Global Data USD $5,995 More Info
MediPoint: Women’s Health - Global Analysis and Market Forecasts
MediPoint: Women’s Health - Global Analysis and Market ForecastsSummaryThe women’s health medical de...
01 Nov 2015 by Global Data USD $6,495 More Info
MediPoint: Endoscopy - Global Analysis and Market Forecasts
MediPoint: Endoscopy - Global Analysis and Market ForecastsSummaryThe global endoscopy market is a d...
01 Nov 2015 by Global Data USD $6,495 More Info
MediPoint: Compression Therapy - Global Analysis and Market Forecasts
MediPoint: Compression Therapy - Global Analysis and Market ForecastsSummaryCompression therapy prod...
01 Oct 2015 by Global Data USD $6,495 More Info

This report is published by Global Data

Download Free Report Summary PDF

MediPoint: Point of Care Diagnostics - Global Analysis and Market Forecasts | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...